| |
| |
|
| Insider
Information: |
Flynn Karen |
| Relationship: |
|
| City: |
Lionville |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
113,719 |
|
|
Indirect Shares
|
1,550 |
|
|
| Direct
Value |
$9,668,734 |
|
|
|
Indirect Value
|
$514,073 |
|
|
| Total
Shares |
115,269 |
|
|
| Total
Value |
$10,182,807 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
West Pharmaceutical Services Inc |
WST |
|
2019-02-19 |
23,692 |
2017-12-01 |
1,550 |
Premium* |
|
|
Societal CDMO, Inc |
SCTL |
Director |
2019-12-05 |
39,283 |
2016-12-16 |
0 |
Premium* |
|
|
Catalent, Inc. |
CTLT |
Director |
2023-10-27 |
24,339 |
2020-01-08 |
0 |
Premium* |
|
|
Quanterix Corp |
QTRX |
|
2024-01-02 |
26,405 |
2022-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
87 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-02-14 |
4 |
A |
$86.93 |
$351,980 |
D/D |
4,049 |
17,691 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-02-17 |
4 |
D |
$83.13 |
$7,149 |
D/D |
(86) |
17,605 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-08-11 |
4 |
A |
$84.93 |
$600 |
I/I |
7 |
1,235 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-08-25 |
4 |
A |
$85.43 |
$738 |
I/I |
9 |
1,244 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-09-08 |
4 |
A |
$91.43 |
$738 |
I/I |
8 |
1,252 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-09-22 |
4 |
A |
$95.21 |
$738 |
I/I |
8 |
1,260 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-10-06 |
4 |
A |
$95.45 |
$738 |
I/I |
8 |
1,267 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-10-20 |
4 |
A |
$93.84 |
$738 |
I/I |
8 |
1,275 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-11-03 |
4 |
A |
$100.95 |
$738 |
I/I |
7 |
1,283 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-11-17 |
4 |
A |
$98.96 |
$738 |
I/I |
7 |
1,290 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-12-01 |
4 |
A |
$99.11 |
$738 |
I/I |
7 |
1,298 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2017-12-29 |
4 |
A |
$98.67 |
$738 |
D/D |
7 |
17,723 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2018-02-13 |
4 |
A |
$93.00 |
$359,910 |
D/D |
3,870 |
21,593 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2018-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,183 |
6,983 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2018-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,274 |
20,257 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2018-08-07 |
4 |
S |
$116.23 |
$2,377,833 |
D/D |
(20,458) |
21,593 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2018-08-07 |
4 |
OE |
$21.22 |
$477,294 |
D/D |
20,458 |
42,051 |
0 |
- |
|
| WST |
West Pharmaceutical Servi... |
Sr VP & Chief Commercial Offic |
• – – |
2019-02-19 |
4 |
A |
$102.51 |
$215,168 |
D/D |
2,099 |
23,692 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2019-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
7,955 |
28,212 |
0 |
- |
|
| SCTL |
Societal CDMO, Inc |
Director |
– • – |
2019-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
11,071 |
39,283 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2020-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
35,286 |
35,286 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2020-04-09 |
4 |
A |
$56.46 |
$20,269 |
D/D |
359 |
35,645 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2020-07-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,476 |
37,121 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2021-01-04 |
4 |
AS |
$104.42 |
$10,338 |
D/D |
(99) |
37,022 |
0 |
% |
|
| CTLT |
Catalent, Inc. |
Pres. Biologics & CCO |
• – – |
2021-01-11 |
4 |
AS |
$112.14 |
$278,279 |
D/D |
(2,478) |
34,544 |
0 |
% |
|
87 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
